Brief: Annexin Pharmaceuticals Q4 Loss SEK 15.9 Mln
Feb 3 (Reuters) - Annexin Pharmaceuticals AB (publ)
ANNX.ST :
* Q4 PROFIT FOR THE PERIOD AMOUNTED TO SEK -15,900 THOUSAND
(-16,374)
* Q4 EARNINGS PER SHARE AMOUNTED TO SEK -0.15 (-0.23)
Source text for Eikon: ID:nWkr2Vpy5j
Further company coverage: ANNX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))
Recent news on Annexin Pharmaceuticals AB (publ)
See all newsBrief: Annexin Pharmaceuticals Q3 Net Loss At SEK 9.5 Mln
Brief: Annexin Pharmaceuticals Q2 2026 Net Loss SEK 11.6 Mln
Brief: Annexin Pharmaceuticals Gets International Nonproprietary Name Drug Candidate Anxv
Brief: Annexin Pharmaceuticals Updates On Nine Patients Treated In Nexus Study
Brief: Annexin's Rights Issue 98% Subscribed